Concepedia

Paola Biason

PB

Statistics

Publications

19

Citations

1.4K

H-Index

15

Active since

2001

Affiliations

Centro di Riferimento Oncologico(Current)

Istituto Oncologico Veneto

University of Padua

Istituti di Ricovero e Cura a Carattere Scientifico

University of Udine

Paola Biason is an author at Centro di Riferimento Oncologico specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2001–2021

19

Publications

19

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

Giuseppe Toffoli, Erika Cecchin, Giuseppe Corona et al. · Journal of Clinical Oncology · 2006 · 337 citations · Full text

, , +17

Predictive Role of the <i>UGT1A1</i>, <i>UGT1A7</i>, and <i>UGT1A9</i> Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan

Erika Cecchin, Federico Innocenti, Mario D’Andrea et al. · Journal of Clinical Oncology · 2009 · 217 citations · Full text

, , +17

Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases

Fotios Loupakis, Shruti Sharma, Madiha Derouazi et al. · JCO Precision Oncology · 2021 · 128 citations · Full text

, , +17

Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes

Fotios Loupakis, Ilaria Depetris, Paola Biason et al. · The Oncologist · 2020 · 112 citations · Full text

, , +17

Class 1, 2, and 3 <i>BRAF</i> -Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization

Marta Schirripa, Paola Biason, Sara Lonardi et al. · Clinical Cancer Research · 2019 · 107 citations · Full text

, , +17

1–5 of 19